Literature DB >> 29633080

Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line.

Lama Hamadneh1, May Al-Majawleh2, Yazun Jarrar2, Sawsan Shraim2, Mariam Hasan2, Basha'er Abu-Irmaileh3.   

Abstract

The levels of DNA methylation and their role in gene expression are key factors that could affect diagnosis, prognosis, and treatment options of different diseases. In this study, the methylation levels of 22 genes that are mostly correlated to breast cancer were determined using EpiTect methyl II PCR array. This analysis was performed to determine the effect of cells' passage number and the use of antibiotics in the culturing media on gene methylation levels in MCF7 cell line. DNA methylation levels of PTGS2, ADAM23, HIC1, and PYCARD were found to be significantly different among different passages. While the DNA methylation levels of CCNA1, RASSF1, and THBS1 were found to be affected by the use of 1% of penicillin/streptomycin in the culture media. Gene expression analysis after demethylation using 5-Aza-2'-deoxycytidine showed that the gene expression levels of the hypermethylated genes varied between different passage numbers. This study shows that the presence of antibiotic within cultured media and cell line's passage number could greatly affect the methylation levels that need to be considered in future studies on cell lines.

Entities:  

Keywords:  Breast cancer; DNA methylation; Passage number; Penicillin/streptomycin; mcf-7 cell line

Mesh:

Substances:

Year:  2018        PMID: 29633080     DOI: 10.1007/s11626-018-0245-7

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  24 in total

1.  The EpiTect Methyl qPCR Assay as novel age estimation method in forensic biology.

Authors:  Shakhawan K Mawlood; Lynn Dennany; Nigel Watson; Benjamin S Pickard
Journal:  Forensic Sci Int       Date:  2016-04-14       Impact factor: 2.395

2.  The effect of cell passage number on osteogenic and adipogenic characteristics of D1 cells.

Authors:  K Kwist; W C Bridges; K J L Burg
Journal:  Cytotechnology       Date:  2015-07-25       Impact factor: 2.058

3.  CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers.

Authors:  Ivana Fridrichova; Bozena Smolkova; Viera Kajabova; Iveta Zmetakova; Tomas Krivulcik; Michal Mego; Zuzana Cierna; Marian Karaba; Juraj Benca; Daniel Pindak; Martin Bohac; Vanda Repiska; Ludovit Danihel
Journal:  Transl Res       Date:  2015-01-09       Impact factor: 7.012

4.  The receptor tyrosine kinase EphA2 is a direct target gene of hypermethylated in cancer 1 (HIC1).

Authors:  Bénédicte Foveau; Gaylor Boulay; Sébastien Pinte; Capucine Van Rechem; Brian R Rood; Dominique Leprince
Journal:  J Biol Chem       Date:  2011-12-19       Impact factor: 5.157

5.  DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors.

Authors:  Jovana Klajic; Florence Busato; Hege Edvardsen; Nizar Touleimat; Thomas Fleischer; Ida Bukholm; Anne-Lise Børresen-Dale; Per Eystein Lønning; Jörg Tost; Vessela N Kristensen
Journal:  Clin Cancer Res       Date:  2014-10-07       Impact factor: 12.531

Review 6.  Noninvasive DNA methylation biomarkers in colorectal cancer: A systematic review.

Authors:  Meng Xue; San Chuan Lai; Zhi Peng Xu; Liang Jing Wang
Journal:  J Dig Dis       Date:  2015-12       Impact factor: 2.325

7.  Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.

Authors:  Ellen Heitzer; Monika Artl; Martin Filipits; Margit Resel; Ricarda Graf; Bettina Weißenbacher; Sigurd Lax; Michael Gnant; Fritz Wrba; Richard Greil; Otto Dietze; Friedrich Hofbauer; Gerhard Böhm; Gerald Höfler; Hellmut Samonigg; Renate Schaberl-Moser; Marija Balic; Nadia Dandachi
Journal:  Mod Pathol       Date:  2013-12-06       Impact factor: 7.842

8.  Development of Castration Resistant Prostate Cancer can be Predicted by a DNA Hypermethylation Profile.

Authors:  Javier C Angulo; Guillermo Andrés; Nadia Ashour; Manuel Sánchez-Chapado; Jose I López; Santiago Ropero
Journal:  J Urol       Date:  2015-11-06       Impact factor: 7.450

Review 9.  DNA methylation and cancer.

Authors:  Partha M Das; Rakesh Singal
Journal:  J Clin Oncol       Date:  2004-11-15       Impact factor: 44.544

10.  Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.

Authors:  Zhu-Qing Zhou; Wei-Hua Cao; Jian-Jun Xie; Jing Lin; Zhong-Ying Shen; Qing-Ying Zhang; Jin-Hui Shen; Li-Yan Xu; En-Min Li
Journal:  BMC Cancer       Date:  2009-08-22       Impact factor: 4.430

View more
  4 in total

1.  Preeclampsia-Associated Alteration of DNA Methylation in Fetal Endothelial Progenitor Cells.

Authors:  Lars Brodowski; Tristan Zindler; Sandra von Hardenberg; Bianca Schröder-Heurich; Constantin S von Kaisenberg; Helge Frieling; Carl A Hubel; Thilo Dörk; Frauke von Versen-Höynck
Journal:  Front Cell Dev Biol       Date:  2019-03-19

2.  Comparison of Global DNA Methylation Patterns in Human Melanoma Tissues and Their Derivative Cell Lines.

Authors:  Euan J Rodger; Suzan N Almomani; Jackie L Ludgate; Peter A Stockwell; Bruce C Baguley; Michael R Eccles; Aniruddha Chatterjee
Journal:  Cancers (Basel)       Date:  2021-04-28       Impact factor: 6.639

3.  Serial Passaging of RAW 264.7 Cells Modulates Intracellular AGE Formation and Downregulates RANKL-Induced In Vitro Osteoclastogenesis.

Authors:  Tanzima Tarannum Lucy; A N M Mamun-Or-Rashid; Masayuki Yagi; Yoshikazu Yonei
Journal:  Int J Mol Sci       Date:  2022-02-21       Impact factor: 5.923

4.  IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening.

Authors:  Ina Puscas; Florian Bernard-Patrzynski; Martin Jutras; Marc-André Lécuyer; Lyne Bourbonnière; Alexandre Prat; Grégoire Leclair; V Gaëlle Roullin
Journal:  Pharmaceutics       Date:  2019-11-08       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.